Tocilizumab for refractory morphea in adults: A case series
Sarah Lonowski, MD, MBA,
Nathaniel Goldman, BA,
Bina Kassamali, BA,
Neda Shahriari, MD,
Avery LaChance, MD, MPH,
Ruth Ann Vleugels, MD, MPH, MBA
Affiliations
Sarah Lonowski, MD, MBA
Department of Dermatology, Brigham and Women’s Hospital, Boston, Massachusetts
Nathaniel Goldman, BA
Department of Dermatology, Brigham and Women’s Hospital, Boston, Massachusetts; New York Medical College, School of Medicine, Valhalla, New York
Bina Kassamali, BA
Department of Dermatology, Brigham and Women’s Hospital, Boston, Massachusetts; Harvard Medical School, School of Medicine, Boston, Massachusetts
Neda Shahriari, MD
Department of Dermatology, Brigham and Women’s Hospital, Boston, Massachusetts
Avery LaChance, MD, MPH
Department of Dermatology, Brigham and Women’s Hospital, Boston, Massachusetts; Harvard Medical School, School of Medicine, Boston, Massachusetts
Ruth Ann Vleugels, MD, MPH, MBA
Department of Dermatology, Brigham and Women’s Hospital, Boston, Massachusetts; Harvard Medical School, School of Medicine, Boston, Massachusetts; Correspondence to: Ruth Ann Vleugels, MD, MPH, MBA, Brigham and Women’s Hospital Department of Dermatology, Harvard Medical School, 221 Longwood Ave, Boston, MA 02115.
